Mistrust of vaccines runs deep in African-American communities. Against formidable odds, Father Paul Abernathy and his teams are trying to convince residents of Pittsburgh’s historic Black neighborhoods to volunteer for trials testing a Covid-19 shot.
A civilian team at a base in Maryland disposed of Syrian toxins a decade ago after hundreds of people were killed in a nerve agent…
A new study is “a bit of a counterweight to the endless hyperbole about how incredibly complex and powerful the human brain is,” one researcher…
More than half of the cats at the sanctuary in Shelton, Wash., died of the virus over the past several weeks.
More than half of the cats at the sanctuary in Shelton, Wash., died of the virus over the past several weeks.
It may be a longstanding practice, but critics say routine weight measurements are driving some patients away from care.
A billionaire gave $1,000 to University of Massachusetts Dartmouth graduates in May. You had to be there.
Researchers identified one key breakthrough for GLP-1 drugs in the 1980s, but Pfizer walked away.
Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.
Employees of SpaceX have filed a formal petition to create the city of Starbase. Its first mayor would be a security manager for the company.
There is no one factor that causes autism — or explains its growing prevalence. Researchers are seeking explanations for the surge. Here are some possibilities.
